Agoracom Blog Home

Archive for the ‘Namaste Technologies Inc.’ Category

« Older Entries
Newer Entries »

Namaste $N.ca Signs Non-Binding LOI to Acquire Up to 25% Equity in Leading Same-Day Cannabis Delivery Service Pineapple Express Delivery Inc $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 9:30 AM on Wednesday, April 25th, 2018

Nlogo

  • Signed a non-binding letter of intent with Pineapple Express Delivery Inc.
  • Namaste will invest $1,000,000 to acquire 15% of the share capital of Pineapple Express and:
  • Obtain a right of first refusal to purchase an additional 10% of the share capital for an additional $1,200,000

VANCOUVER, British Columbia, April 25, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that it has signed a non-binding letter of intent (“LOI”) with Pineapple Express Delivery Inc. (“Pineapple Express”), whereby Namaste will invest $1,000,000 to acquire 15% of the share capital of Pineapple Express and obtain a right of first refusal to purchase an additional 10% of the share capital for an additional $1,200,000.

Pineapple Express currently operates a same-day delivery service for medical cannabis and expects to expand across Canada. Pineapple Express’ management team have a proven track record of launching cross-country same-day delivery services, having sold a previous same-day delivery venture to Just Eat Canada.

The proposed agreement will allow Namaste and Pineapple Express to expand on Pineapple Express’ existing same-day delivery service for medical cannabis platform to provide same-day delivery of medical cannabis across Canada. Namaste intends to assist with the development and marketing of Pineapple Express’ brand and in the optimization of its existing software platform. Namaste will also look to leverage its international exposure and offer Pineapple Express’ fully-integrated software application to international cannabis licensed producers.

The Company along with Pineapple Express will retain exclusive rights to use the Pineapple Express software platform in North America, and Namaste will hold the rights to use the software platform internationally. Pineapple Express has also signed an LOI with Canada’s leading seed-to-sale platform, Ample Organics Inc., to offer same-day delivery to its customers.

Terms of the LOI

  • Namaste will make an initial capital investment of $1,000,000 for 15% of the share capital of Pineapple Express. The initial capital investment will be comprised of $850,000 in cash and $150,000 in Namaste common stock, subject to exchange approval.
  • Namaste will receive a right of first refusal to acquire an additional 10% interest in Pineapple Express for $1,200,000 for 14 months following the closing date of the definitive agreement. This payment would be comprised of $780,000 in cash and $420,000 in Namaste common stock, subject to exchange approval.
  • Namaste will reserve for issuance up to 150,000 common share options (the “Options”) to be issued to Pineapple Express and/or its officers pursuant to consulting agreements entered into on execution of the definitive agreement. The Options will vest on a quarterly basis. Namaste will reserve up to 150,000 Options for issuance each year to Pineapple Express and/or its officers for so long as they have consulting agreements with Namaste.
  • Namaste and Pineapple Express will jointly hold the exclusive rights to Pineapple Express’ software and technology in North America. Namaste will solely hold the exclusive worldwide rights outside of North America to use Pineapple Express’ software and have a right to sublicense.

Management Commentary

Randy Rolph, President and CEO of Pineapple Express: “we are excited by the prospect of partnering with Namaste, as I see this as an excellent fit for both companies. Namaste has built an excellent reputation within the medicinal cannabis industry and has focused on expanding its services so that its customers benefit from a wider array of product offerings. As an extension of these efforts, we believe that our company can ensure their customers get a secure delivery of these products within a very quick turnaround from time of order. Through other businesses, we have successfully offered fast product delivery options for over 10 years across Canada, including same day as well as deliveries in less than one hour. We are familiar with the issues and most importantly the solutions to bring similar levels of service to the medicinal cannabis industry. Customer service has always been our main focus and what has driven the success of our business. We look forward to offering this same level of service to all customers.”

Sean Dollinger, President and CEO of Namaste comments: “We are very pleased to have signed this LOI to acquire shares of an amazing company offering a unique service with a proven record of success. As the cannabis market continues to grow, so too has the competitiveness among our industry peers looking to expand their market share. We believe that our ability to offer same-day delivery service for medical cannabis will provide a competitive edge to the Company in terms of offering an incredible buying experience for our patients. Namaste’s mandate from the outset has been focused on providing patients with unparalleled customer service. This transaction reaffirms our team’s ability to identify shortcomings within the cannabis industry, seek viable solutions, and then explore opportunities that aim to further enhance our patient’s experience. We believe this transaction will not only help Namaste attract new patients, but more importantly, it will help us retain patients who see value in the services we provide. We look forward to working with Pineapple Express’ management team and to grow its business and expand internationally. We are very grateful for this opportunity and look forward to cultivating a strong partnership together.”

About Pineapple Express Delivery Inc.

Pineapple Express’ management team has over 10 years of experience offering same-day 60-minute delivery services in multiple industries across Canada, and has successfully integrated with Ample Organics Inc., Canada’s leading seed-to-sale medical cannabis software platform. Pineapple Express offers a personalized experience for its customers and has established in depth security and delivery protocols to facilitate same-day delivery of medical cannabis across the country. Pineapple Express is dedicated to providing patients with a fully integrated, simple to use, same-day delivery platform which it believes brings great value to medical patients across the country. For more information visit: www.pineappleexpressdelivery.ca

About Namaste Technologies Inc.

Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through 24 e-commerce sites in 20 countries and with distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis sales license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Direct: +1 (786) 389 9771

Email: [email protected]

Further information on Namaste and its products can be accessed through the links below:

namastetechnologies.com

namastevapes.ca

everyonedoesit.ca

namastevaporizers.co.uk

everyonedoesit.co.uk

australianvaporizers.com.au

Forward Looking Information

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. The Canadian Securities Exchange has neither reviewed nor approved the contents of this press release.

Tags: , , , , , , , ,
Posted in All Recent Posts, Featured, Namaste Technologies Inc. | Comments Off on Namaste $N.ca Signs Non-Binding LOI to Acquire Up to 25% Equity in Leading Same-Day Cannabis Delivery Service Pineapple Express Delivery Inc $ACB.ca $HIP.ca $WEED.ca $CMED.ca

The medical #marijuana industry is about to get much bigger, CannTrust CEO says $N.ca $NXTTF $TBP.ca $MCOA $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 12:11 PM on Friday, April 20th, 2018
  • The ramp up in Canada’s cannabis sector is ongoing
  • Industry estimates of sales eventually adding up to between $5 and $8 billion a year
  • By comparison, Canada produces a little under $3 billion of beer a year and about $1 billion in tobacco products.

April 19, 2018 By Jayson MacLean

Eric Paul

While all eyes are on the launch date for recreational cannabis in Canada —said to come in either late summer or early fall— the medical side of the equation should be getting the attention, as well, because it’s about to get much bigger, says Eric Paul, CEO of licensed producer CannTrust Holdings (TSX:TRST).

The ramp up in Canada’s cannabis sector is ongoing, with industry estimates of sales eventually adding up to between $5 and $8 billion a year. That’s substantial, since by comparison, Canada produces a little under $3 billion of beer a year and about $1 billion in tobacco products.

But while the rec market is getting all the focus, the medical marijuana industry both at home and abroad should be getting its props, since it’s growing by leaps and bounds.

“We’ve been astounded by the growth of the medical marijuana industry in Canada,” Eric Paul, CEO of CannTrust Holdings, tells BNN.

“Roughly ten or 12 per cent of the 80,000 doctors across Canada who could prescribe are prescribing [cannabis], and I would say we’re gaining on that for a number of reasons,” says Paul. “The first being the opiate crisis where doctors are looking for cannabis as a potential first-line therapy for pain management. The second thing is that there is more research coming out; we’re about to announce a couple of major research projects in Canada and one is a major pain management study. As these research projects produce their end result, more doctors are looking at cannabis as an alternate therapy for chronically ill people.”

Statistics Canada has reported that between April and December of last year, the number of clients registered under its Access to Cannabis for Medical Purposes Regulations (ACMPR) has gone from 174,503 to 269,502.

Paul says that CannTrust itself has a 40,000-strong patient base and is looking to jump to 100,000 in 12 months time.

“We’ve had a major expansion in Niagara: a 430,000 sq. ft. state of the art greenhouse which is up and running,” says Paul. “We believe that with that capacity and with the nature of that facility, we’ll be able to supply our current customer demand in the medical market and have sufficient capacity to handle the first generation of recreational demand.”

But aside from Canada’s own growing medical market, the international market is poised to take off in countries like Germany and Australia, and many of the top licensed producers in Canada are now lining up deals outside of Canada.

In March, CannTrust announced that it has entered into a joint venture agreement with a Danish company to grow and sell medical cannabis.

“The industry is globalizing much faster than any of us expected,” says Paul.

“Various countries are going into medical legislation and Denmark is one of those countries that have announced that we’re fully licensed there, we’ll be building a facility there,” he said. “In that country, the government has decided to fund the cost of it for the consumer, via prescription, and they’re willing to fund 100 per cent for people with palliative or end-of-life care and 50 per cent for chronic illness. That will allow those industries to quickly garner market share. Germany is a similar kind of situation and also Australia.”

Source: https://www.cantechletter.com/2018/04/the-medical-marijuana-industry-is-about-to-get-much-bigger-canntrust-ceo-says/

Tags: , , , , , ,
Posted in All Recent Posts, Marijuana Company of America, Medical Marijuana Stocks, Namaste Technologies Inc., Tetra Bio-Pharma Inc. | Comments Off on The medical #marijuana industry is about to get much bigger, CannTrust CEO says $N.ca $NXTTF $TBP.ca $MCOA $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Namaste Receives Conditional Approval to List on TSX Venture Exchange $N.ca $NXTTF $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 9:22 AM on Thursday, April 19th, 2018

Nlogo

  • Received conditional approval to list the common shares and warrants of the Company on the TSX Venture Exchange as a Tier 1 issuer
  • listing is subject to the Company fulfilling certain requirements of the TSXV in accordance with the terms of its conditional approval letter dated April 18th, 2018

VANCOUVER, British Columbia, April 19, 2018 — Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that it has received conditional approval to list the common shares and warrants of the Company on the TSX Venture Exchange (“TSXV”) as a Tier 1 issuer. The listing is subject to the Company fulfilling certain requirements of the TSXV in accordance with the terms of its conditional approval letter dated April 18th, 2018. The Company anticipates that the common shares will continue to trade under the trading symbol “N” and its warrants will continue to trade under the symbol “N.WT.”

The Company will proceed expeditiously to satisfy these conditions and management is confident that all conditions for listing will be met. Upon obtaining final approval, the Company will issue a further press release to inform shareholders when it anticipates that its common shares and warrants will commence trading on the TSXV.

Management Commentary

Sean Dollinger, President and CEO of Namaste comments: “We are very pleased to have received conditional approval from the TSXV. We’re also proud to have been accepted as a Tier 1 issuer. We believe that this listing will provide the company and its shareholders with many advantages, including greater visibility and enhanced market access for Canadian and international investors. We’re extremely proud to join the ranks of many innovative cannabis companies in our industry and gain new exposure through a larger exchange. We will remain committed to expanding our business strategy through innovation to help solidify our position in the cannabis sector.

I’d like to take this opportunity to thank the Canadian Securities Exchange (“CSE”) for their tremendous support. We greatly appreciate the CSE for providing us with a platform for Namaste to grow and we’re excited to be moving forward towards the anticipated TSXV listing.”

About Namaste Technologies Inc.

Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through 24 e-commerce sites in 20 countries and with distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis sales licence (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Direct: +1 (786) 389 9771

Email: [email protected]

 

Further information on Namaste and its products can be accessed through the links below:

namastetechnologies.com

namastevapes.ca

everyonedoesit.ca

namastevaporizers.co.uk

everyonedoesit.co.uk

australianvaporizers.com.au

Forward Looking Information

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. The Canadian Securities Exchange has neither reviewed nor approved the contents of this press release.

Tags: , , , , ,
Posted in All Recent Posts, Namaste Technologies Inc. | Comments Off on Namaste Receives Conditional Approval to List on TSX Venture Exchange $N.ca $NXTTF $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Medical #marijuana making a big difference in the lives of sick children and their families $TBP.ca $N.ca $NXTTF $MCOA $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 11:06 AM on Wednesday, April 11th, 2018

“That makes all of the work we did worthwhile.”

ByCharlie Deitch @CharlieDee71

CP photo by Renee Rosensteel, Hannah Pallas laughs with her mother, Heather Shuker

Stretched out in his recliner, Ryan Briggs is having a great nap. Laying there in his Bob Marley T-shirt, you can hear him gently snoring. Although his slumber is intermittently interrupted by a slight seizure, this is starting out as a good day.

At just 18, Briggs has already had a pretty rough life. When he was born, doctor error caused the child to go more than 20 minutes without oxygen. Briggs lived, but is nonverbal and unable to care for himself. Worse than that, though, were the seizures. He experienced close to 500 of them every day — some smaller, others larger and more violent. He received all kinds of treatments and medication, but few of them helped; some made things even worse. But his mother, Diana Briggs, was determined to keep looking for that one thing that would help.

“We went everywhere for treatment,” she says. “We did one called the starvation diet, we did hyperbaric treatments and even went out of the country for stem-cell treatments. But nothing seemed to help. The seizures would get so bad, and they were frequent. We tracked every one of them. In fact, that’s how my youngest daughter learned to count, by counting her brother’s seizures.”

In 2014, Briggs saw a video that changed her life. It provided the same epiphany that parents across the state would have as the video was shared widely. The video showed that oil extracted from marijuana worked to stop the seizures of a 5-year-old Colorado girl named Charlotte Figi. Subsequently, a large group of parents across the state banded together to fight to bring medical marijuana to Pennsylvania. It was an uphill fight, but on April 17, 2016, Gov. Tom Wolf signed the legislation into law, and earlier this year, Pennsylvanians could begin legally purchasing medical cannabis.

There is no question that without the parents of sick children stepping forward to fight this battle, the law would never have been approved. But, as Briggs says, “It’s easy to say no to an adult, but it’s pretty hard to do that to a sick kid who’s suffering.”

click to enlarge

  • Ryan Briggs and his family pose for a photo with Gov. Tom Wolf the day he signed the medical-marijuana bill into law.

When the World Medical Cannabis Conference & Expo opens in Pittsburgh later this week, there will be many panels on “children and cannabis.” With that in mind, City Paper checked in on some families who have spent the past four years fighting for legalization and see how their lives have changed. Aside from Briggs, we also talked to Heather Shuker, an outspoken advocate for the product and the mother of Hannah Pallas, a 15-year-old who has dealt with intractable epilepsy her entire life.

“A few years ago, Hannah was confined to a chair, she never smiled, she couldn’t lift her extremities, she was non-verbal,” Shuker says, as a walking, squealing Hannah moves about their apartment from room to room. “Look at her now. She has found her voice, and she has found her smile again. It’s an amazing transformation.”

An obvious positive of medical-marijuana dispensaries opening up across the state is having available product close by. But for many parents, this won’t be the first time they’ve purchased these medications. Last year, the state enacted a safe-harbor provision that made it legal for anyone who is qualified to receive the drug to have it in their possession. Many parents began going out of state for the product, and since it was still illegal in several states, transporting it over state lines was a felony. For other parents, though, having safe-harbor protections still wasn’t their first foray into buying medical marijuana.

“I haven’t talked about this much before, obviously, but we’ve been experimenting with Hannah’s medication for a few years now,” Shuker says. Sometime between 2014 and 2015, Shuker began going out of state to get medical-marijuana products. She always traveled by plane and brought the oils back with her on the plane, a nerve-wracking experience. “I knew it was a risk, and I knew it would be bad if I got caught, because someone could try to take Hannah away,” she says. “But my daughter was sick, with zero quality of life. I had to help her, so at the end of the day, it wasn’t really a choice at all.”

Briggs had the same feeling that Shuker did. She would fly to Colorado to get medication and bring it back with her. Once, because of some change she forgot to take out of her pocket, she was pulled aside and given a complete search, including having her bags searched. They didn’t find the oil, but it made for a tense moment.

Because of the cost of going to Denver and the risk, she decided to find a local contact. While she won’t give many details about the person or the transactions, she says the dealer became part of the family.

“That first Christmas, I baked him some cookies,” Briggs says. “I didn’t think it was strange at the time. I’m a mom — that’s what we do for family and friends, we bake cookies.”

The other thing moms do is help others in need.

Source: https://www.pghcitypaper.com/pittsburgh/medical-marijuana-making-a-big-difference-in-the-lives-of-sick-children-and-their-families/Content?oid=7667617

Tags: , ,
Posted in All Recent Posts, Marijuana Company of America, Medical Marijuana Stocks, Namaste Technologies Inc., Tetra Bio-Pharma Inc. | Comments Off on Medical #marijuana making a big difference in the lives of sick children and their families $TBP.ca $N.ca $NXTTF $MCOA $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Namaste $N.ca Announces March 2018 Sales of C$1.24M Representing a 74% Year-on-Year Increase and Acquires 535 New Patients Representing a 142% Month-on-Month Increase $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 9:26 AM on Friday, April 6th, 2018

Nlogo

  • March net revenue C$1,249,670
    • 74% revenue increase in March 2018 when compared to March 2017
  • Namaste MD acquired 535 new medical cannabis patients on the NamasteMD platform
    • 142% month-over-month increase of patients
    • Company anticipates further acceleration of the growth
    • will be key driver of future revenue

VANCOUVER, British Columbia, April 06, 2018 —Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce March 2018 total unaudited net revenue as reported by the Company (including shipping revenues and after discounts and refunds) were C$1,249,670, representing a 74% revenue increase in March 2018 when compared to March 2017. Namaste’s management team is also pleased to report that the Company’s wholly owned subsidiary, Namaste MD Inc. (“NamasteMD”), has acquired 535 new medical cannabis patients on the NamasteMD platform, representing a 142% month-over-month increase of patients. NamasteMD allows patients to consult with doctors or nurse practitioners for medical cannabis in a simple and convenient platform from the comfort of their homes. The Company anticipates further acceleration of the growth in the NamasteMD patient network and expects that NamasteMD will be key driver of future revenue.

The table below display’s Namaste’s total gross sales by revenue channel.

Management Commentary

Sean Dollinger, President and CEO of Namaste comments; “We are very pleased to be seeing the positive trend of monthly sales increases year-over-year. What is most exciting is our increasing rate of patient acquisition on NamasteMD. With minimal outside marketing we were quietly able to bring on nearly 1,000 patients by the end of the March. We are working on expanding our nurse practitioner team with our partners at O Cannabis we Stand on Guard for Thee Inc. (“O Cannabis”) to accommodate the anticipated growth of patients. We strongly believe that our patients will be a key to our success, along with our strategy to provide our patients with not only the best care but also the largest and best variety of medical cannabis products. We’re proud to be innovating the industry by changing the way that patients access medical cannabis and look forward to continued growth through both the medical cannabis and hardware platforms.”

About Namaste Technologies Inc.

Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through 24 e-commerce sites in 20 countries and with distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis sales licence (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Direct: +1 (786) 389 9771

Email: [email protected]

 

Further information on Namaste and its products can be accessed through the links below:

namastetechnologies.com

namastevapes.ca

everyonedoesit.ca

namastevaporizers.co.uk

everyonedoesit.co.uk

australianvaporizers.com.au

Forward Looking Information

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. The Canadian Securities Exchange has neither reviewed nor approved the contents of this press release.

Tags: , , , , ,
Posted in All Recent Posts, Featured, Medical Marijuana Stocks, Namaste Technologies Inc. | Comments Off on Namaste $N.ca Announces March 2018 Sales of C$1.24M Representing a 74% Year-on-Year Increase and Acquires 535 New Patients Representing a 142% Month-on-Month Increase $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Namaste $N.ca Announces Share Purchase and Medical #Cannabis Licensed Dealer Application Letter of Intent With 2624078 Ontario Inc

Posted by AGORACOM-JC at 10:00 AM on Thursday, April 5th, 2018

Nlogo

  • Company has signed a non-binding letter of intent (“LOI”) with 2624078 Ontario Inc.
  • Namaste would acquire 51% of the share capital of 2624078 Ontario Inc., which will undertake an application to become a Licensed Dealer (“LD”) of medical cannabis, in accordance with Health Canada regulations

VANCOUVER, British Columbia, April 05, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRANKFURT:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that the Company has signed a non-binding letter of intent (“LOI”) with 2624078 Ontario Inc., whereby Namaste would acquire 51% of the share capital of 2624078 Ontario Inc., which will undertake an application to become a Licensed Dealer (“LD”) of medical cannabis, in accordance with Health Canada regulations. Licensed dealers are authorized to perform research and development, analytical testing and conducting clinical studies with medical cannabis as well as importing medical cannabis for research purposes. The location for the LD facility is at 7 Canso Road in Etobicoke, Ontario and directly across the street from Namaste’s wholly owned subsidiary, Cannmart Inc.’s Access to Cannabis for Medical Purposes (“ACMPR”) facility. The purpose of Namaste’s investment and partnership with 2624078 Ontario Inc. is to facilitate research and development of medical cannabis extracts as well as for testing of imported medical cannabis products in accordance with ACMPR guidelines. Namaste’s partnership with 2624078 Ontario Inc. reinforces Namaste’s position as a leader in the medical cannabis industry and helps ensure that it will be a first-mover in the research and production of cannabis concentrates as it anticipates a growing demand for extracts in the future.

Key LOI Terms:

  • Namaste will acquire 51% of the share capital of 2624078 Ontario Inc.
  • Namaste and will provide debt financing of up to $750,000 CAD to complete construction of the LD facility.
  • 2624078 Ontario Inc.’s existing management team will sign 3-year management agreements to provide operational oversight of the facility.
  • Both parties will have 30 days from the date of execution of the LOI to negotiate terms of definitive documentation which will include a share purchase agreement and management agreements.
  • The facility at 7 Canso Road will be constructed to meet ACMPR standards

The LOI and proposed share purchase agreement represent a significant milestone for Namaste in securing a facility that will facilitate the importation of unique strains of medical cannabis for testing purposes, as well as research and production of high potency cannabis extracts.  If an LD license is obtained, Namaste will be able to import medical cannabis from international partners for the purpose of testing the product against ACMPR standards. In addition to providing the ability to import medical cannabis for research purposes, the LD license would also allow Namaste to begin research and development of medical cannabis extracts. Currently, the Company estimates that cannabis extract sales in the US represent over 50% of all dispensary sales. As Namaste anticipates further expansion of Canada’s legal medical cannabis platform, it expects to see significant industry trends towards these higher potency products. This LOI and the implications of obtaining an LD license for Namaste would ensure the Company’s position in what it expects to become a strong segment of the Canadian medical cannabis industry in the future.

Management Commentary

Daniel Stern, President and CEO of 2624078 Ontario Inc. comments; “We are very excited to be working with Namaste on this project. We believe that our experience in cannabis extraction technology and many years of experience in the general cannabis industry will facilitate the success of this partnership with Namaste, who we believe is a leading innovator in the Canadian medical cannabis community.”

Sean Dollinger, President and CEO of Namaste comments; “We are very pleased to have signed this LOI as we feel confident in the future of medical cannabis extracts in the Canadian marketplace. Although high potency concentrates are not yet approved under ACMPR regulations, the LD license will provide Namaste with the opportunity to take the first steps towards not only researching and producing extracts but also engage in the process of importing medical cannabis for testing purposes. The management team of 2624078 Ontario Inc. has shown confidence in Namaste’s leadership abilities as demonstrated through our success in the industry to date. The launch of NamasteMD and our pending ACMPR sales license coupled with this LOI and the application for an LD license are important building blocks to solidify Namaste’s position as a leader in the Canadian medical cannabis industry.”

About Namaste Technologies Inc.

Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through 24 e-commerce sites in 20 countries and with distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors

“Sean Dollinger”
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: [email protected]

Further information on the Company and its products can be accessed through the links below:

NamasteTechnologies.com
NamasteMD.com
NamasteVapes.ca
Everyonedoesit.ca

FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

Tags: , ,
Posted in All Recent Posts, Namaste Technologies Inc. | Comments Off on Namaste $N.ca Announces Share Purchase and Medical #Cannabis Licensed Dealer Application Letter of Intent With 2624078 Ontario Inc

Namaste $N.ca Announces Canada’s First Large-Scale National Prospective Observational Study to Observe the Impact of Medical #Cannabis Use for Anxiety Treatment $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 9:51 AM on Wednesday, April 4th, 2018

Nlogo

  • Initiated Canada’s first large-scale prospective study on a national platform called the Cannabis for Anxiety Reduction study, to determine the effectiveness of cannabis in reducing anxiety in study participants
  • One in four Canadians suffer from anxiety and the Company through this study will seek to gain valuable information from study participants on the impact of medical cannabis use in relation to their anxiety

VANCOUVER, British Columbia, April 04, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRANKFURT: M5BQ) (OTCMKTS:NXTTF) is pleased to announce that it has initiated Canada’s first large-scale prospective study on a national platform called the Cannabis for Anxiety Reduction study, to determine the effectiveness of cannabis in reducing anxiety in study participants. One in four Canadians suffer from anxiety and the Company through this study will seek to gain valuable information from study participants on the impact of medical cannabis use in relation to their anxiety. Namaste is also interested in determining the safety profile of patients using medical cannabis, and whether strain and dose of medical cannabis may impact patient reductions in anxiety ratings. The study will be available to all Canadians and will be conducted under the following conditions:

  • Prospective patients must be over 25 years of age.
  • Patients must score 8 or above Hospital Anxiety and Depression Scale (HADS).
  • The study will span over a 3-month period for each registered patient.
  • The study will be submitted for approval to the Veritas Independent Review Board (IRB) prior to commencement.
  • The primary investigator in the study is a nurse practitioner.
  • Patients can self-refer into the study (without referral through a doctor or specialist).

Namaste plans to offer this study to its patients which are registered under the Company’s wholly-owned subsidiary and virtual patient platform, NamasteMD Inc. (“NamasteMD”). Patients suffering from anxiety under the terms outlined above may participate in the study. This study is the first large-scale anxiety study in the nation, establishing Namaste as an innovator in research related to anxiety and cannabis. This is also the first national study where the primary investigator is a nurse practitioner. The Company intends to conduct similar studies in various areas where patients can benefit from the use of medical cannabis. The data collected from the study is valuable for the Company as well as the industry as a whole. The study may be published in peer-reviewed research journals and other medical publications.

For more information on this study please email [email protected]

Management Commentary

Sean Dollinger, President and CEO of Namaste comments; “We are very pleased to have initiated this study with the help of our partners at O-Cannabis. As many people in Canada suffer from varying forms of anxiety, we believe that many of these patients can benefit from the use of medical cannabis instead of prescription pharmaceutical drugs. We hope this study will provide very valuable information for Namaste and for the industry. We encourage qualifying patients to participate and look forward to seeing the results. We plan to undertake additional studies to bring awareness and a better understanding of how medical cannabis can benefit Canadians. We believe that these studies will help Namaste by attracting a larger base of patients and help solidify Namaste’s position as a leader in the Canadian medical cannabis industry.”

About Namaste Technologies Inc.

Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through 24 e-commerce sites in 20 countries and with distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors

“Sean Dollinger”
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: [email protected]

Further information on the Company and its products can be accessed through the links below:

NamasteTechnologies.com
NamasteMD.com
NamasteVapes.ca
Everyonedoesit.ca

FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

 

Tags: , , , ,
Posted in All Recent Posts, Medical Marijuana Stocks, Namaste Technologies Inc. | Comments Off on Namaste $N.ca Announces Canada’s First Large-Scale National Prospective Observational Study to Observe the Impact of Medical #Cannabis Use for Anxiety Treatment $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Could medical #marijuana help curb the #opioid crisis? #MMJ $N.ca $TBP.ca $MCOA

Posted by AGORACOM-JC at 5:10 PM on Tuesday, April 3rd, 2018
  • Medical marijuana could help quell the ongoing opioid epidemic, a pair of new studies contends.
  • Opioid prescriptions tend to decrease in U.S. states that adopt medical marijuana laws or legalize recreational use of pot, two different research teams have concluded.

The studies couldn’t prove cause and effect. But one study found that opioids dispensed through Medicare’s prescription drug plan decreased significantly if people had access to medical pot dispensaries or were allowed to grow marijuana for their own use.

“We had about a 14.5 percent reduction in opiate use when states turned on dispensaries, and about a 7 percent reduction in opiate use when states turned on home cultivation-based cannabis laws,” said researcher David Bradford, chairman of public policy at the University of Georgia School of Public and International Affairs.

The other study, led by researcher Hefei Wen, from the University of Kentucky College of Public Health, found a decrease in opioid prescriptions covered by Medicaid in states that legalized either medicinal or recreational pot.

Both types of laws were linked to about a 6 percent decline in opioid prescribing, researchers reported.

“We do think there’s good reason to be hopeful that cannabis might be one tool out of many we could use to address the opioid epidemic,” Bradford said.

Drug overdoses killed nearly 64,000 Americans in 2016, with two-thirds of deaths involving a prescription or illicit opioid, the U.S. Centers for Disease Control and Prevention reported last week. Overdose deaths rose 21.5 percent in 2016, a much sharper spike than the 11.4 percent increase seen the previous year.

At this point, 30 states and the District of Columbia have laws legalizing some form of marijuana use, including eight states that have legalized recreational use.

Studies have found medical pot is effective in treating chronic pain, Bradford said. In 2017, the prestigious National Academies of Sciences, Engineering and Medicine issued a report concluding that pot can significantly reduce pain symptoms.

Both research teams suspected that if this were true, then medical marijuana might ease opioid use in people with chronic pain.

To investigate this theory, the investigators turned to recent data from the federal insurance programs Medicare and Medicaid. They compared opioid prescribing patterns between states with medical or recreational pot and those that have taken a hard line against weed.

An average state filled 23 million daily doses of opioids through Medicare’s prescription drug plan between 2010 and 2015, Bradford’s team found.

But states with medical pot dispensaries filled 3.7 million fewer daily doses, and states with home cultivation filled 1.8 million fewer doses, they said.

Results did vary based on the type of opioid, however. Medical pot was linked to reductions in hydrocodone, morphine and fentanyl prescriptions, but not to prescriptions for oxycodone, Bradford said. The second study found a similar effect among people covered by Medicaid.

The two studies were published online April 2 in JAMA Internal Medicine.

“I think at this point, with patients dying every day as a result of opioid use disorder, we need to consider all possible solutions to the crisis,” said Dr. Kevin Hill, director of addiction psychiatry at Beth Israel Deaconess Medical Center in Boston and an assistant professor of psychiatry at Harvard Medical School. “Papers like these two suggest that cannabis may play a role.”

He said these studies and others offer strong support for anecdotal evidence from patients who report they need fewer opioids for chronic pain when they are put on medical cannabis. Hill wrote an editorial that accompanied the two articles.

At the same time, Hill says medical marijuana should not be given a lead role in treating chronic pain. Instead, it should be a back-up option for patients who are struggling to manage pain and who could be in danger of addiction.

“I think it’s hard to deny that there is a growing body of evidence that suggests a role for cannabis in treating chronic pain, but it’s not the level where it would be a first-line or even second-line treatment,” Hill said.

Source: https://www.cbsnews.com/news/could-medical-marijuana-help-curb-the-opioid-crisis/

Tags: , , ,
Posted in All Recent Posts, Marijuana Company of America, Medical Marijuana Stocks, Namaste Technologies Inc. | Comments Off on Could medical #marijuana help curb the #opioid crisis? #MMJ $N.ca $TBP.ca $MCOA

Namaste $N.ca $NXTTF Announces Appointment of Laurens Feenstra, Branden Spikes and Don Nickless to Board of Directors $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 9:59 AM on Wednesday, March 28th, 2018

Nlogo

  • Nominees and proposed board members have served in critical roles at Google, SpaceX and Seagram’s International
  • Bringing an intangible amount of value in helping advance the Company’s technology through innovation
  • Having individuals of this pedigree join Namaste at this point in the business cycle provides immediate legitimacy to the company and will help expedite Namaste’s plans to continue on the path of revolutionizing the cannabis industry

VANCOUVER, British Columbia, March 28, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRANKFURT:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that following the company’s Annual General Meeting of shareholders (“AGM”), which was held at the law offices of Gowling WLG (Canada) LLP on Tuesday, March 27, 2018, the Company has appointed Branden Spikes, Laurens Feenstra and Donald William Nickless (the “Board Appointees”) for positions on Namaste’s 2018 board of directors. The Board Appointees mark a pivotal milestone for Namaste in solidifying the board and supporting the Company’s future growth within the cannabis industry. The Nominees and proposed board members have served in critical roles at Google, SpaceX and Seagram’s International, and bring an intangible amount of value in helping advance the Company’s technology through innovation.

Namaste has been very selective in the appointment in these directors, as it looks to expand on its already impressive list of products and services. Each appointee brings an incredible amount of expertise in their respective discipline, and Namaste believes their experience will help further differentiate Namaste within the cannabis market, as an innovator in the space. Having individuals of this pedigree join Namaste at this point in the business cycle provides immediate legitimacy to the company and will help expedite Namaste’s plans to continue on the path of revolutionizing the cannabis industry.

The Nominees’ bios and experience are outlined below:

Laurens Feenstra – Laurens Feenstra is currently Product Manager at Waymo, formerly known as Google’s self-driving car project. Prior to Waymo, he worked on some of Google’s most well-known products such as Search, Chromebooks, and Android. As a strategy consultant at McKinsey & Company, he has helped large media, banking and government clients become data analytics-driven companies. Mr. Feenstra holds degrees in Human-Computer Interaction and Artificial Intelligence from University of Groningen in the Netherlands, and was a visiting researcher on “Intelligent Tutoring Systems” at Carnegie Mellon University. When not working on the latest technology, he organizes small electronic music festivals and runs a Burning Man camp.

Branden Spikes – Branden Spikes, considered as “Elon Musk’s most trusted lieutenant” by Venture Beat, worked side by side with Musk for over 15 years and helped pioneer ground breaking technologies at SpaceX, Tesla, and PayPal. He was the CIO of SpaceX for ten years and was instrumental in setting up the information systems at Tesla Motors during its formative years after having served as Director of IT at PayPal. Spikes then founded Spikes Security in 2012, with a mission to solve the most pressing cybersecurity challenge, browser malware and served as its CEO until it merged with Aurionpro in 2017. Mr. Spikes is an investor, advisor and a technology evangelist.

Donald William Nickless – Mr. Nickless graduated from Macdonald College of McGill University with a BSc in Agriculture. Mr. Nickless then worked for thirty plus years working for the Seagram Company Limited, beginning as a front-line supervisor in manufacturing, progressing through various Department Head positions to the manager of the Company’s largest Canadian plant. Subsequent, Mr. Nickless held various positions that culminated in the appointment to Executive Vice President of Manufacturing, Seagram Americas with responsibility for Manufacturing Operations in the US, Canada, and South America. Mr. Nickless is now retired and living in Vermont as a “Gentleman Farmer”.

In connection with these nominations, Peter Simeon and Philip van den Berg have stepped down from the Company’s board of directors.

We would also like to thank Peter Simeon and Philip van den Berg for serving on the Board.  Peter will continue to serve as legal counsel and corporate secretary to the Company and Philip will continue to serve as Chief Financial Officer.

Management Commentary

Sean Dollinger, President and CEO of Namaste comments, “I’ve always believed that successful companies are the direct by-product of building exceptional teams. The appointment of Branden Spikes, Laurens Feenstra and Donald William are a testament to that belief, and I am extremely excited to have them join our team. These Nominees further strengthen our corporate structure as we continue to build the foundation of our company, as we look to create a unique identity in the cannabis space through innovation.  To date, Namaste has demonstrated its commitment to innovation through the adoption and implementation of many one-of-a-kind initiatives, and we fully intend on taking that philosophy to the next level with the addition of these highly experienced and well respected individuals.  As the cannabis market continues to evolve at a rapid pace, we are of the opinion that Namaste must continue to come up with inventive ways to appeal to cannabis patients on a global scale.   We believe collectively that these individuals  will help facilitate future growth opportunities  and help set Namaste apart  from others looking to capitalize on this exciting industry.”

About Namaste Technologies Inc.

Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through 24 e-commerce sites in 20 countries and with distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors

“Sean Dollinger”
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: [email protected]

Further information on the Company and its products can be accessed through the links below:

NamasteTechnologies.com
NamasteMD.com
NamasteVapes.ca
Everyonedoesit.ca

FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

Tags: , , , , ,
Posted in All Recent Posts, Medical Marijuana Stocks, Namaste Technologies Inc. | Comments Off on Namaste $N.ca $NXTTF Announces Appointment of Laurens Feenstra, Branden Spikes and Don Nickless to Board of Directors $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Namaste $N.ca $NXTTF Announces Signing of a Medical Cannabis Product Acquisition Agreement With Colombian Licensed Producer Clever Leaves $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 8:38 AM on Monday, March 26th, 2018

Nlogo

  • Announced that it has signed a medical cannabis Product Acquisition Agreement under the Company’s wholly owned subsidiary, Cannmart Inc. with Clever Leaves
  • Supply Agreement represents further progress in Namaste securing medical cannabis supply agreements with global partners
  • Namaste, subject to approval by Health Canada, will continue to pursue importation of high-quality medical cannabis, sourced from internationally licensed producers

VANCOUVER, British Columbia, March 26, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that it has signed a medical cannabis Product Acquisition Agreement (the “Supply Agreement”) under the Company’s wholly owned subsidiary, Cannmart Inc. (“Cannmart”), with Clever Leaves (Ecomedics S.A.S.), a vertically integrated,  licensed producer of medical cannabis in Colombia, with the assistance of Clever Leaves’ financial sponsor, Northern Swan Holdings, Inc. (“Northern Swan”). Clever Leaves has recently broken ground on a 15+ hectare Good Agricultural Collection Practices (“GACP”) compliant cultivation facility and Good Manufacturing Practices (“GMP”) Level-2 Extraction facility, leveraging high-grade technology and practices from the international pharmaceutical and cannabis industries. By 2019, development of a second Colombian cultivation site will significantly expand its cultivation capacity to meet the growing demand from domestic and international patients. This Supply Agreement represents further progress in Namaste securing medical cannabis supply agreements with global partners. Namaste, subject to approval by Health Canada, will continue to pursue importation of high-quality medical cannabis, sourced from internationally licensed producers.

Key Terms of the Supply Agreement:

  • Cannmart will submit purchase orders to Clever Leaves for medical cannabis.
  • Cannmart will import medical cannabis from Clever Leaves, subject to approval by Health Canada.
  • Cannmart will be compliant with Clever Leaves’ branding and pricing strategy.
  • Cannmart will be responsible for shipping and importation costs of the product.
  • Clever Leaves will provide Cannmart with lab test reports for each purchase in advance and in accordance with Cannmart’s requirements under Canadian regulations.
  • The packaging of products will bear the Clever Leaves brand logo.

The Supply Agreement with Clever Leaves further supports Namaste’s strategy of providing its Canadian patients with access to high-quality imported medical cannabis. The Company believes Clever Leaves’ production expertise and quality control methods will meet the highest standard of requirements necessary for importation into the Canadian market. Namaste will continue to cultivate international relationships under the guidelines set forth by Health Canada, in an attempt to position Cannmart as one of the most diverse global e-commerce platforms.

Management Commentary

Andrés Fajardo, Chairman of Clever Leaves comments; “We are thrilled to enter into a partnership with Namaste and to help carry out Colombia’s vision of becoming a leading supplier of medicinal cannabis to the world.  We believe this agreement is a validation of the professionalism of our operation, and by forging long-term win-win partnerships with best in class groups around the world, such as Namaste, we are sure to achieve this and more.”

Sean Dollinger, President and CEO of Namaste comments; “We’re very pleased to be announcing this Supply Agreement with Clever Leaves. In addition to sourcing cannabis products from domestic producers, our goal is to offer Canadian patients with the most diverse offering of medical cannabis products from high quality international cultivators. The Clever Leaves management team has proven themselves as experts in the cultivation of medical cannabis, and we are extremely excited at the potential of offering our patients access to a variety of products, which we believe will greatly benefit our patients. We remain focused on implementing this strategy, and we look forward to the launch of Cannmart. We further anticipate the signing of additional supply agreements and partnerships with industry-leading licensed producers, and we feel confident in the direction we are headed. It has been extremely rewarding to see the willingness of top producers and industry leaders to collaborate with Namaste in a joint effort to revolutionize the cannabis industry. Namaste’s management team looks forward to moving forward and working with Clever Leaves team to bring value to its patients.”

About Clever Leaves

Clever Leaves is a vertically-integrated licensed producer of medical cannabis.  Located in Colombia, Clever Leaves has broken ground on an industrial Good Agricultural Collection Practices (“GACP”) compliant cultivation facility and Good Manufacturing Practices (“GMP”) Level-2 Extraction facility, capable of producing up to 15,000,000 ml of cannabis oil per year.  By leveraging the highest-grade technology and practices from the international pharmaceutical and cannabis industries, Clever Leaves is positioned to lead the production of low-cost, high grade medical cannabis extracts for global exportation. For more information, visit en.cleverleaves.com

About Northern Swan

Northern Swan is a New York-based investment firm focused on early and late-stage investments in the legal cannabis industry. Northern Swan delivers a comprehensive solution for financing and advising licensed cannabis operators globally. Northern Swan’s investment professionals have collectively invested in excess of $3 billion of capital at Blackstone, KKR, and Och-Ziff.  For more information, visit www.northernswan.com

About Namaste Technologies Inc.

Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through 24 e-commerce sites in 20 countries and with distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

Further information on Namaste and its products can be accessed through the links below:

namastetechnologies.com

namastevapes.ca

everyonedoesit.ca

namastevaporizers.co.uk

everyonedoesit.co.uk

australianvaporizers.com.au

Contacts
Namaste
On behalf of the Board of Directors
“Sean Dollinger”
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: [email protected]

Clever Leaves
Andrés Fajardo
Chairman
Email: [email protected]

Northern Swan
Kyle Detwiler
Chief Executive Officer
Direct: +1 (646) 880 4382
Email: [email protected]

Forward Looking Information

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. The Canadian Securities Exchange has neither reviewed nor approved the contents of this press release.

Tags: , , ,
Posted in All Recent Posts, Featured, Namaste Technologies Inc. | Comments Off on Namaste $N.ca $NXTTF Announces Signing of a Medical Cannabis Product Acquisition Agreement With Colombian Licensed Producer Clever Leaves $ACB.ca $HIP.ca $WEED.ca $CMED.ca

« Older Entries
Newer Entries »